Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Depreciation and Depletion (2017 - 2025)

cbdMD's Depreciation and Depletion history spans 9 years, with the latest figure at $54160.0 for Q4 2025.

  • For Q4 2025, Depreciation and Depletion fell 49.26% year-over-year to $54160.0; the TTM value through Dec 2025 reached $308483.0, down 31.17%, while the annual FY2025 figure was $361063.0, 20.18% down from the prior year.
  • Depreciation and Depletion for Q4 2025 was $54160.0 at cbdMD, down from $70788.0 in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $340701.0 in Q4 2021 and bottomed at $54160.0 in Q4 2025.
  • The 5-year median for Depreciation and Depletion is $114912.0 (2024), against an average of $160926.7.
  • The largest annual shift saw Depreciation and Depletion surged 176.79% in 2021 before it plummeted 70.62% in 2022.
  • A 5-year view of Depreciation and Depletion shows it stood at $340701.0 in 2021, then tumbled by 70.62% to $100112.0 in 2022, then grew by 10.74% to $110864.0 in 2023, then decreased by 3.72% to $106740.0 in 2024, then plummeted by 49.26% to $54160.0 in 2025.
  • Per Business Quant, the three most recent readings for YCBD's Depreciation and Depletion are $54160.0 (Q4 2025), $70788.0 (Q3 2025), and $88906.0 (Q2 2025).